Yanhuai (Richard) Ding is an experienced professional in the field of process development and manufacturing operations, currently serving as Senior Director CMC DS at EvolveImmune Therapeutics. Previous roles include Director and Head of Purification Process Development at Biogen, Director of Downstream Process Development, MSAT, and Manufacturing Operations at AnaptysBio, and Principal Scientist in Downstream Process Development at Thermo Fisher Scientific. At Therapeutic Proteins International, LLC, Yanhuai (Richard) Ding held the position of Sr. Manager, leading Downstream Process Development. Academic credentials include a Sr. Post Doctorial Fellowship in Protein Chemistry from the University of Massachusetts Amherst and a Post Doctorial Fellowship in Biochemistry and Molecular Biology from Penn State University.